JP2008521884A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008521884A5 JP2008521884A5 JP2007544016A JP2007544016A JP2008521884A5 JP 2008521884 A5 JP2008521884 A5 JP 2008521884A5 JP 2007544016 A JP2007544016 A JP 2007544016A JP 2007544016 A JP2007544016 A JP 2007544016A JP 2008521884 A5 JP2008521884 A5 JP 2008521884A5
- Authority
- JP
- Japan
- Prior art keywords
- sodium
- composition
- ceftriaxone
- sulbactam
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2411/DEL/2004 | 2004-12-02 | ||
| IN2411DE2004 | 2004-12-02 | ||
| PCT/IN2005/000382 WO2006059344A1 (en) | 2004-12-02 | 2005-11-28 | Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008521884A JP2008521884A (ja) | 2008-06-26 |
| JP2008521884A5 true JP2008521884A5 (enExample) | 2008-12-18 |
| JP5269415B2 JP5269415B2 (ja) | 2013-08-21 |
Family
ID=35789266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007544016A Expired - Fee Related JP5269415B2 (ja) | 2004-12-02 | 2005-11-28 | 注射に有用なβ−ラクタマーゼ阻害剤を使用したβ−ラクタマーゼ媒介性の抗生物質耐性を抑制する組成物 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US8273732B2 (enExample) |
| EP (1) | EP1841432B1 (enExample) |
| JP (1) | JP5269415B2 (enExample) |
| KR (2) | KR20070067189A (enExample) |
| CN (1) | CN101060846A (enExample) |
| AT (1) | ATE476981T1 (enExample) |
| AU (1) | AU2005310888B2 (enExample) |
| BR (1) | BRPI0517128A (enExample) |
| CY (1) | CY1110886T1 (enExample) |
| DE (1) | DE602005022939D1 (enExample) |
| DK (1) | DK1841432T3 (enExample) |
| ES (1) | ES2349301T3 (enExample) |
| HR (1) | HRP20100591T1 (enExample) |
| MX (1) | MX2007006540A (enExample) |
| NZ (1) | NZ555075A (enExample) |
| PL (1) | PL1841432T3 (enExample) |
| PT (1) | PT1841432E (enExample) |
| RS (1) | RS51506B (enExample) |
| RU (1) | RU2397768C2 (enExample) |
| SI (1) | SI1841432T1 (enExample) |
| UA (1) | UA91204C2 (enExample) |
| WO (1) | WO2006059344A1 (enExample) |
| ZA (1) | ZA200704394B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030010176A (ko) * | 2001-07-25 | 2003-02-05 | 이병두 | 은행 열매 추출물과 호도 열매 추출물을 이용한 천식 치료제 |
| CN101129381B (zh) * | 2006-08-25 | 2012-02-01 | 天津和美生物技术有限公司 | 含β-内酰胺类抗生素和离子螯合剂的抗生素复方 |
| CN101129382B (zh) * | 2006-08-25 | 2013-12-25 | 天津和美生物技术有限公司 | 含β-内酰胺类抗生素和缓冲组分的抗生素复方 |
| JP5639471B2 (ja) * | 2008-07-28 | 2014-12-10 | 惠三 山口 | 感染症治療効果増強剤 |
| CN101537009B (zh) * | 2009-04-30 | 2010-09-15 | 海口奇力制药股份有限公司 | 注射用头孢曲松钠他唑巴坦钠复方制剂的生产工艺 |
| JP2012176899A (ja) * | 2009-05-19 | 2012-09-13 | Mitsubishi Tanabe Pharma Corp | ２−（１−ピペラジニル）−５−メチルベンゼンスルホン酸誘導体を含む注射用水溶液 |
| EP3412289A1 (en) * | 2011-05-28 | 2018-12-12 | Wockhardt Limited | Antibacterial compositions |
| EP2768503A1 (en) * | 2011-07-26 | 2014-08-27 | Wockhardt Limited | Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor |
| WO2013042140A2 (en) * | 2011-09-23 | 2013-03-28 | Manu Chaudhary | Non antibiotic,non peptide compounds for antibiotic efficacy & safety enhancement |
| MY169816A (en) | 2012-03-26 | 2019-05-16 | Santen Pharmaceutical Co Ltd | Ophthalmic solution comprising diquafosol |
| EP2858636B1 (en) | 2012-06-07 | 2018-09-05 | Childrens Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
| US20150306076A1 (en) * | 2012-09-27 | 2015-10-29 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine antibiotic compositions |
| MX2016010699A (es) | 2014-02-18 | 2017-10-11 | Children's Hospital Los Angeles | Composiciones y metodos para tratar neutropenia. |
| EP3125887A1 (en) * | 2014-03-29 | 2017-02-08 | Wockhardt Limited | Pharmaceutical compositions comprising cefepime or sulbactam |
| SG11201509950TA (en) * | 2014-04-03 | 2016-01-28 | Kewpie Kabushiki Kaisha Also Trading As Kewpie Corp | Injection fluid bag and injection preparation |
| US10201518B2 (en) | 2016-09-28 | 2019-02-12 | The University Of Hong Kong | Bismuth(III) compounds and methods thereof |
| JP6891275B2 (ja) * | 2016-11-02 | 2021-06-18 | 湘北威爾曼制薬股▲分▼有限公司Ｘｉａｎｇｂｅｉ Ｗｅｌｍａｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．，Ｌｔｄ | セフトリアキソンナトリウムとスルバクタムナトリウムからなる組成物 |
| CN111249284B (zh) * | 2016-11-03 | 2022-10-04 | 湘北威尔曼制药股份有限公司 | 治疗淋病奈瑟菌感染的头孢曲松钠舒巴坦钠 |
| RU2665006C1 (ru) * | 2017-02-28 | 2018-08-24 | Общество с ограниченной ответственностью "Супербаг Солюшенс" | Композиция антимикробных препаратов для лечения инфекционных заболеваний людей и животных и способ её применения |
| EP4272831A3 (en) | 2018-08-09 | 2024-02-21 | Antabio SAS | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
| US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
| EP4262860A4 (en) | 2020-12-17 | 2025-11-12 | Idexx Lab Inc | DETECTION AND TREATMENT OF ROCKY MOUNTAIN SPRINKLE FEVER |
| WO2025165991A1 (en) * | 2024-01-31 | 2025-08-07 | The Penn State Research Foundation | Biopolymeric anti-antibiotics and methods for making and using the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6630510B1 (en) * | 1999-10-28 | 2003-10-07 | Merck & Co., Inc. | Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections |
| US6677320B2 (en) * | 2000-01-20 | 2004-01-13 | Hoffmann-La Roches Inc. | Parenteral bisphosphonate composition with improved local tolerance |
| PL1468697T3 (pl) * | 2003-04-14 | 2008-05-30 | Wyeth Corp | Kompozycje zawierające piperacyklinę i tazobaktam przydatne do wstrzykiwań |
-
2005
- 2005-11-28 RS RSP-2010/0465A patent/RS51506B/sr unknown
- 2005-11-28 CN CNA2005800395645A patent/CN101060846A/zh active Pending
- 2005-11-28 MX MX2007006540A patent/MX2007006540A/es active IP Right Grant
- 2005-11-28 US US11/720,710 patent/US8273732B2/en not_active Expired - Fee Related
- 2005-11-28 AU AU2005310888A patent/AU2005310888B2/en not_active Ceased
- 2005-11-28 UA UAA200707280A patent/UA91204C2/ru unknown
- 2005-11-28 WO PCT/IN2005/000382 patent/WO2006059344A1/en not_active Ceased
- 2005-11-28 PL PL05817957T patent/PL1841432T3/pl unknown
- 2005-11-28 JP JP2007544016A patent/JP5269415B2/ja not_active Expired - Fee Related
- 2005-11-28 KR KR1020077010375A patent/KR20070067189A/ko not_active Ceased
- 2005-11-28 SI SI200531130T patent/SI1841432T1/sl unknown
- 2005-11-28 DE DE602005022939T patent/DE602005022939D1/de not_active Expired - Lifetime
- 2005-11-28 BR BRPI0517128-8A patent/BRPI0517128A/pt not_active IP Right Cessation
- 2005-11-28 EP EP05817957A patent/EP1841432B1/en not_active Expired - Lifetime
- 2005-11-28 KR KR1020097018388A patent/KR101244362B1/ko not_active Expired - Fee Related
- 2005-11-28 ES ES05817957T patent/ES2349301T3/es not_active Expired - Lifetime
- 2005-11-28 RU RU2007124325/15A patent/RU2397768C2/ru not_active IP Right Cessation
- 2005-11-28 HR HR20100591T patent/HRP20100591T1/hr unknown
- 2005-11-28 DK DK05817957.3T patent/DK1841432T3/da active
- 2005-11-28 PT PT05817957T patent/PT1841432E/pt unknown
- 2005-11-28 NZ NZ555075A patent/NZ555075A/en not_active IP Right Cessation
- 2005-11-28 AT AT05817957T patent/ATE476981T1/de active
-
2007
- 2007-05-29 ZA ZA200704394A patent/ZA200704394B/xx unknown
-
2010
- 2010-11-10 CY CY20101101012T patent/CY1110886T1/el unknown
-
2012
- 2012-09-25 US US13/626,236 patent/US9012442B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008530082A5 (enExample) | ||
| TWI342212B (en) | Liquid pharmaceutical formulations of palonosetron | |
| US6028222A (en) | Stable liquid paracetamol compositions, and method for preparing same | |
| RU2007124325A (ru) | Композиции для преодоления опосредованной бета-лактамазой резистентности к антибиотикам с использованием ингибитора бета-лактамазы, предназначенные для инъекции | |
| CN1289084C (zh) | 药物制剂 | |
| JP6745798B2 (ja) | パラセタモール及びイブプロフェンを含む水性配合物 | |
| CN1396828A (zh) | 含有培美西德以及一硫代甘油l－半胱氨酸或巯乙酸的药物组合物 | |
| BRPI0612447A2 (pt) | composição antibiótica de dose fixa, processo para a preparação de um produto de combinação antibiótica de dose fixa, processo para a preparação de uma injeção lìquida e usos de pó seco para injeção e injeção lìquida | |
| EP2588097B1 (en) | Pharmaceutical compositions comprising paracetamol and process for preparing the same | |
| US9125905B2 (en) | Liquid pharmaceutical formulations of palonosetron | |
| JP7777518B2 (ja) | リファブチンの処置方法、使用および組成物 | |
| JP5203191B2 (ja) | エンド−ｎ−（９−メチル−９−アザビシクロ［３．３．１］ノン−３−イル）−１−メチル−１ｈ−インダゾール−３−カルボキサミド塩酸塩の医薬製剤 | |
| CN114306218B (zh) | 满足药学抑菌要求的经粘膜给药r-氯胺酮药物组合物 | |
| WO2009081283A2 (en) | Aqueous formulations of acetaminophen for injection | |
| JP5811404B2 (ja) | セトロンを頬側経粘膜投与するための処方物（ｆｏｒｍｕｌａｔｉｏｎ） | |
| JP2018048096A (ja) | 液体製剤、及び、パロノセトロンの安定性を向上する方法 | |
| KR101169478B1 (ko) | 용액 의약조성물 | |
| WO2014062568A2 (en) | Amoxicillin formulation and method of using such formulation | |
| WO2014083071A1 (en) | Injectable liquid formulation of the combination of tramadol and paracetamol | |
| JPWO2009075309A1 (ja) | 製剤組成物 | |
| WO2024151603A1 (en) | Hydromorphone formulations for multi-dose products | |
| US20250319066A1 (en) | Injectable dmt formulations | |
| WO2007069070A2 (en) | Aseptically filled multidose injectable dosage forms of granisetron |